These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25163360)

  • 1. What is new in IVF?
    Kovacs GT
    Med J Aust; 2014 Sep; 201(5):244-5. PubMed ID: 25163360
    [No Abstract]   [Full Text] [Related]  

  • 2. The prevention of ovarian hyperstimulation syndrome.
    Corbett S; Shmorgun D; Claman P; ;
    J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports.
    Martínez F; Rodríguez DB; Buxaderas R; Tur R; Mancini F; Coroleu B
    Fertil Steril; 2011 Jun; 95(7):2432.e17-9. PubMed ID: 21513932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian hyperstimulation: effects of GnRH analogues. Ovarian hyperstimulation syndrome after using gonadotrophin-releasing hormone analogue as a trigger of ovulation: causes and implications.
    Kol S; Lewit N; Itskovitz-Eldor J
    Hum Reprod; 1996 Jun; 11(6):1143-4. PubMed ID: 8671407
    [No Abstract]   [Full Text] [Related]  

  • 5. Ovarian hyperstimulation: effects of GnRH analogues. Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome?
    Casper RF
    Hum Reprod; 1996 Jun; 11(6):1144-6. PubMed ID: 8671408
    [No Abstract]   [Full Text] [Related]  

  • 6. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders.
    Bar-Hava I; Mizrachi Y; Karfunkel-Doron D; Omer Y; Sheena L; Carmon N; Ben-David G
    Fertil Steril; 2016 Aug; 106(2):330-3. PubMed ID: 27114332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos.
    Garcia-Velasco JA
    Fertil Steril; 2012 Mar; 97(3):527-8. PubMed ID: 22222191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction: Contemporary approaches to alternative ovarian stimulation strategies for in vitro fertilization.
    Paulson RJ
    Fertil Steril; 2017 Oct; 108(4):555-557. PubMed ID: 28911928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in ovulation trigger strategies.
    Dosouto C; Haahr T; Humaidan P
    Panminerva Med; 2019 Mar; 61(1):42-51. PubMed ID: 30674181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [GnRH agonist triggering in IVF and luteal phase support in women at risk of ovarian hyperstimulation syndrome].
    Guivarc'h-Levêque A; Jaffré F; Homer L; Moy L; Priou G; Colleu D; Denis I; Arvis P
    Gynecol Obstet Fertil; 2013 Sep; 41(9):511-4. PubMed ID: 23972925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic understanding of gonadotropin-releasing hormone-agonist triggering.
    Casper RF
    Fertil Steril; 2015 Apr; 103(4):867-9. PubMed ID: 25712575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
    Zhu YM; Gao HJ; He RH; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian stimulation in ART - Unwinding pressing issues.
    Zech NH; Zech M; Baldauf S; Comploj G; Murtinger M; Spitzer D; Hradecký L; Ajayi R; Schuff M; Zech H
    Minerva Ginecol; 2015 Apr; 67(2):127-47. PubMed ID: 25668422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Friendly IVF: the way of the future?
    Olivennes F; Frydman R
    Hum Reprod; 1998 May; 13(5):1121-4. PubMed ID: 9647528
    [No Abstract]   [Full Text] [Related]  

  • 17. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.
    Griesinger G; Schultz L; Bauer T; Broessner A; Frambach T; Kissler S
    Fertil Steril; 2011 May; 95(6):2029-33, 2033.e1. PubMed ID: 21371705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GnRH agonist triggers and their use in assisted reproductive technology: the past, the present and the future.
    Atkinson P; Koch J; Susic D; Ledger WL
    Womens Health (Lond); 2014 May; 10(3):267-76. PubMed ID: 24956293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger.
    Fatemi HM; Garcia-Velasco J
    Fertil Steril; 2015 Apr; 103(4):870-3. PubMed ID: 25724740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonic control without hormone determination for ovulation induction in in-vitro fertilization/embryo transfer with gonadotrophin-releasing hormone analogue and human menopausal gonadotrophin.
    Golan A; Herman A; Soffer Y; Bukovsky I; Ron-El R
    Hum Reprod; 1994 Sep; 9(9):1631-3. PubMed ID: 7836512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.